ã¡ãã£ã¢èšäº
æ°åã³ããã®mRNAã¯ã¯ãã³æäžãç¯çœªåãã¢ã€ããå·ã§æ°æ³æ¡
ããºãææ°ããŒã¯ 738
twitterã³ã¡ã³ã 669ä»¶äž 401ïœ500件
âïžãã§ã€ã¯ã§ãªããªã
ããããã¥ãŒã¹
ããããã¥ãŒã¹
èãçããªã
ã€ã€ãïŒãã¯ãæ¯ã泚å
¥ããã®ã«çãããããªããæ¯å
¥ãïŒæã€ãªå±éºïŒæã£ããæ»ã¬ã§ãâæªäºº21é¢çžã®èšèãåŒçšããŸããã
ãã£ïŒïŒããžã§ïŒïŒæ¥æ¬å€§äžå€«ããªâŠ
ããããŸãæãåã£ãæ¹åã«æ¯ãåãåºãããªããã£ãšã俺ãä»ã®ç¶æ³ã«ãªãããšãç¥ã£ãŠãããmRNAã¯ã¯ãã³ã¯æããªãã£ããã
å©ç¹ããªã¹ã¯ãã¯ããã«äžåããšãããšããã³ã¹ã瀺ãããŠããããã
ãã¢ã€ããå·è°äŒã«ãŠmRNAã¯ã¯ãã³æäžéæ³åæ³æ¡æåºãå
æ¥ãã€ãŒããã件ããã¥ãŒã¹èšäºã«ãªã£ããèšäºå
šäœã¯ãèšè
ãã¯ã¯ãã³æšé²ã®ç«å ŽããæžããŠããŠåã£ãŠããããå ±éãããããšèªäœã«ã¯å€§ããªæ矩ãããã
æã£ãäºãèšããã¢ã¡ãªã«äººã
ç«å Žäžãæ¬åœã¯ã€ãã€ã¯ã¯ãã³ã ãšæã£ãŠããŠããèšããªãæ¥æ¬äººã
矚ãŸããã
ç«å Žäžãæ¬åœã¯ã€ãã€ã¯ã¯ãã³ã ãšæã£ãŠããŠããèšããªãæ¥æ¬äººã
矚ãŸããã
ã€ãã«ãããŸã§ãããâŠ
ãã¿ã§ãªããŠããŸãã(ïŒÂŽÐïœ)
å°ãã§ãmRNAã¯ã¯ãã³ã«å¯ŸããŠçåãæã€äººãçãåã¯ã¯ããšãåŒã°ããã®ãªããäžçèŠæš¡ã§èŠãã°ãã¯ãåã¯ã¯ã®ã»ããããžã§ãªãã£ã ããªã
ããã
ã¯ã¯ãã³ã¯ãšã³ãµã€ãã»ããªãµã€ããããšããšç¯çœªã§ãããã£ãšäžçãæ°ã¥ãåºããã
ã¯ã¯ãã³æäžããæ¥æ¬ã®å»è
ãæéã®åé¡ãððš
æ©ããçžã«ããŠãããªããšäœåºŠãæã€ç¡ç¥ãªåœæ°ãç ç²ã«ãªã£ã¡ããã
ãªãããð
æ©ããçžã«ããŠãããªããšäœåºŠãæã€ç¡ç¥ãªåœæ°ãç ç²ã«ãªã£ã¡ããã
ãªãããð
æ³æ¡
ãæ¡ãã§ããããïŒ
æ©ãšã¡ãããªãããã«ãé¡ãããŸãã
ãæ¡ãã§ããããïŒ
æ©ãšã¡ãããªãããã«ãé¡ãããŸãã
ãããªã®æ®ºäººçœªã§ããæ¥æ¬ã次æãªããŸããã
殺人ã¯ã¯ãã³èŠå¶ã®çŽ æŽãããæ³æ¡ã«å¯ŸããŠã³ããè³ãã«èšè
ãæããããªé¡ã§æžããææ³æèšäºã
ãã®èšäºã§ãŠããŠãèšããŠãåã¯ã¯ãå
šéšèªãã§ãªãããããã€ãã®äºããïœ
æ³æ¡ãæåº
ã ã¢ã€ããå·ã§ã¯æåºããããæ³æ¡ãéãã®ãéäŸãªã®ããªïŒ
ãããšããã©ãŒãã¹èªã¯ãã»ã³ã»ãŒã·ã§ãã«ãªã¿ã€ãã«ã§é£ã£ãŠãèšäºãèªãŸãªã人ãèžãããŠãäžçãããããããªã·ãŒãªã®ããªïŒ
ã ã¢ã€ããå·ã§ã¯æåºããããæ³æ¡ãéãã®ãéäŸãªã®ããªïŒ
ãããšããã©ãŒãã¹èªã¯ãã»ã³ã»ãŒã·ã§ãã«ãªã¿ã€ãã«ã§é£ã£ãŠãèšäºãèªãŸãªã人ãèžãããŠãäžçãããããããªã·ãŒãªã®ããªïŒ
ã¢ã¡ãªã«ã®ã¢ã€ããå·ã«ããã®æ¬éã£ããïŒç¬
ãã©ãŒãã¹ã£ãŠäœå
å¯ãã ã£ãããª
âŒïžã¯ã¯ãã³æäžðç¯çœªåâŒïž!ðð
ðºðžã¢ã€ããå·ã§æ°åã³ãããŠã€ã«ã¹ææç(COVID-19)ã®mRNA(ã¡ãã»ã³ãžã£ãŒRNA)ã¯ã¯ãã³ãæäžããè¡çºã軜ç¯çœªãšã¿ãªãæ³æ¡ãè°äŒã«æåºãããã
ðºðžã¢ã€ããå·ã§æ°åã³ãããŠã€ã«ã¹ææç(COVID-19)ã®mRNA(ã¡ãã»ã³ãžã£ãŒRNA)ã¯ã¯ãã³ãæäžããè¡çºã軜ç¯çœªãšã¿ãªãæ³æ¡ãè°äŒã«æåºãããã
mRNAã¯ã¯ãã³æäžãããé®æã ã£ãŠãïœïœïœ
æ¥æ¬äºº8å²é®æã ãïœ
æ¥æ¬äºº8å²é®æã ãïœ
ã³ããã¯ã¯ãã³æäžã¯ç¯çœª
ã©ããªãã®ãã
ã©ããªãã®ãã
ã¢ã€ããå·ã§æ°åã³ããmRNAã¯ã¯ãã³ã®æäžã軜ç¯çœªãšã¿ãªãæ³æ¡ãè°äŒã«æåºãããŸãããå
±åå
ã®ãžã¥ãã£ã»ãã€ã«å·äžé¢è°å¡ãå
±åææ¡ããå·æ³HB
ðïžãŸã æ¥æ¬ã§ã¯âŠã
ã§ãè¿ãå°æ¥ïŒããã«ïŒâŠ
ðïžãŸã æ¥æ¬ã§ã¯âŠã
ã§ãè¿ãå°æ¥ïŒããã«ïŒâŠ
éžåïŒæ³æ¡æåº
ååŽçã¯ããèªåãã¡ã®éãèªããŠåœæ°ã«è¬çœªããçŽã¡ã«æ¥çš®ãäžæ¢ããã¹ããä»ããã§ãé
ããªããšæãã
â
â
ãµããã€ãã«ãããããã®ãåºããã§ããã
ãŸã ã¢ã¡ãªã«ã®å Žåã¯å·ã®æ®µéã§ãããäžççã«ã¯mRNAã¯ã¯ãã³ã«é¢ããŠå察éåãèµ·ããŠããäŸã¯ãããªãã«ããã®ã§ãåŸã¯å¯æ±ºãããã©ããã§ãã
ãŸã ã¢ã¡ãªã«ã®å Žåã¯å·ã®æ®µéã§ãããäžççã«ã¯mRNAã¯ã¯ãã³ã«é¢ããŠå察éåãèµ·ããŠããäŸã¯ãããªãã«ããã®ã§ãåŸã¯å¯æ±ºãããã©ããã§ãã
軜ç¯çœªã§ã¯æžãŸãªããã©ãð€¬
æªéã¯å·šå€§æš¹ã«ã«åããããã
æªéã¯å·šå€§æš¹ã«ã«åããããã
ããæ¬åœã ã£ããã ãããããé°è¬è«ããšæã£ãŠãð
ã¢ã€ããå·ã§mRNAã¯ã¯ãã³æäžãç¯çœªãšããæ°æ³æ¡æåºããã
åç©ãžã®æäžã
ããâãã¯ã¹ã察象
åç©ãžã®æäžã
ããâãã¯ã¹ã察象
æ¥æ¬ããããããæ¥çš®ã¯äžæ¢ã«ããæ¹ããšãšãã
å®éšãªãã®ã¯ã¯ãã³ã¯ãå±éºãšé£ãåããã
å®éšãªãã®ã¯ã¯ãã³ã¯ãå±éºãšé£ãåããã
ã©ãããäºãªãã§ãããã
æ©ãçå®ãç¥ãããã§ãã
æ©ãçå®ãç¥ãããã§ãã
èšäºãããã¯æ³æ¡ã«æ¹å€çãªè«èª¿ã ãã©ã³ã¡ã³ãæ¬ã¯ãŸãçéã®æè¿ã ãŒã
æ¥æ¬ã¯ãã¬ãã§ã¢ãã«ããmRNAã¯äººé¡ã®æªæ¥ã®åžæã¿ãããªã€ã¡ãŒãžçŸåCMã倧éã«æµããŠãã
補é å·¥å Žãåå°ã«å»ºèšäºå®ãªã®æ ããªããª
æ¥æ¬ã¯ãã¬ãã§ã¢ãã«ããmRNAã¯äººé¡ã®æªæ¥ã®åžæã¿ãããªã€ã¡ãŒãžçŸåCMã倧éã«æµããŠãã
補é å·¥å Žãåå°ã«å»ºèšäºå®ãªã®æ ããªããª
ãïŒã¯ã¯ãã³ãïŒæ©æéçºãããããšãåé¡èŠããŠããããè¡æ ãå¿èã®åé¡ãæžå¿µããæ
å ±ãããããåºãŠããŠãããšæã ã
ã»ããããæ³¢ããããšããäºãæããŠå®å šãªç©ã§ã¯ãªãäºãç¥ã£ãŠã»ãã
ã»ããããæ³¢ããããšããäºãæããŠå®å šãªç©ã§ã¯ãªãäºãç¥ã£ãŠã»ãã
ãã ã«ãªã£ãŠãã®ã«ã³ããã¯ã¯ãã³äžæ¢ã«ããã©ãããå®ææ¥çš®ãããããªããªããŠæ¥æ¬ã¯äžäœã©ããªã£ãŠãã®ïŒïŒâãã¡ã¯ãã¡ãããã¯ããâã£ãŠããšïŒããŸãã«ãé
·ãããããã®æã«åãã§æã€å»è
ã¯ç¯çœªã ãâŠãã
æªç¥ã®ã¯ã¯ãã³â ïž
ææäºé²ãææé²æ¢ãã§ããªããªãã¯ã¯ãã³ã§ã¯ãªãâŠãã ã®æ¯ð§
ææäºé²ãææé²æ¢ãã§ããªããªãã¯ã¯ãã³ã§ã¯ãªãâŠãã ã®æ¯ð§
ãã®ãã¬ã³ãã®æå³ã¯ãã¯ã¯ãã³ãæã£ã人ãç¯çœªè
ã«ãªããšããããšã
ãã£ãšå€§ããªåé¡ãšããŠåãäžããŠæ¥ãããæ¥æ¬ã¯ããŸã ã¯ã¯ãã³æ¥çš®ãå§ããŠããããã¹ã¯ãåæ°ã®äººãä»ãç¶ãããšèšããããããã¡ã ãã
è°å¡äºäººãæåºããå¯æ±ºæç«ã¯ããŠããªãã
æç«ã¯ããªãããããªãã®ããª?
çµå±èšäºã®å 容ãåŠå®çã§ã¯ããã
ããã®æå³ã¯æ¥æ¬ã§ããããªèšäºãåºããšããããšã«ãæå³ã¯ãããã ãšæãã!
æç«ã¯ããªãããããªãã®ããª?
çµå±èšäºã®å 容ãåŠå®çã§ã¯ããã
ããã®æå³ã¯æ¥æ¬ã§ããããªèšäºãåºããšããããšã«ãæå³ã¯ãããã ãšæãã!
ãããª
ç±³åœã¯æ¥æ¬ãšéã£ãŠãæç«å¯èœæ§ãŒãã®ãžã§ãŒã¯ã®ãããªæ³æ¡ãä¹±çºããããã§ããããããªã®èŠãŠåãã§ãåã¯ã¯ãã³ã«ã¯åããŸãã
ããããâŠ
ãªãã颚åããïŒ
ãªãã颚åããïŒ
ããã¯ã¯ã¯ãã³ãæªããšèšã£ãŠãã®ã§ã¯ãªããŠã矩ååããäºã軜ç¯çœªåã«ãªãå¯èœæ§ããããšã®äºã
èŠåºãã«æªæããããŸããã
èŠåºãã«æªæããããŸããã
ã¢ãã«ãã®ã¯ã¯ãã³ã
4610äžååãå»æ£ ååŽç
ããããåŸãªããïŒæ¯æ¥æ°èïŒ
ã¢ã¡ãªã«ã«ç¡çããè²·ãããã
ããšãã¡ãã£ã¢ã¯å ±éããŸãã
4610äžååãå»æ£ ååŽç
ããããåŸãªããïŒæ¯æ¥æ°èïŒ
ã¢ã¡ãªã«ã«ç¡çããè²·ãããã
ããšãã¡ãã£ã¢ã¯å ±éããŸãã
æžå¿µãããã®ã¯çã£åœãªå»çç§åŠãæ²»çãžã®åœ±é¿
ä»ãè延ã£ãŠãããšã»å»çç§åŠã¯åæ¢ã§åé¡ãªã
äžççã«å»çå«çã¯ã²ã©ãç¶æ³ãããªãããªïŒ
ä»ãè延ã£ãŠãããšã»å»çç§åŠã¯åæ¢ã§åé¡ãªã
äžççã«å»çå«çã¯ã²ã©ãç¶æ³ãããªãããªïŒ
ã¢ã€ããå·ã§ã³ããã¯ã¯ãã³ã®æ¥çš®ãéæ³ã«ãªããŸãã
æ¥æ¬äººã¯äœåç®ãŸã§æã€ã®ããªâŠ
æ¥æ¬äººã¯äœåç®ãŸã§æã€ã®ããªâŠ
å¯æ±ºãããèš³ã§ã¯ç¡ããã©ããã¥ãŒã¹ã§æµããããšã«é©ããã
ã³ããã¯ã¯ãã³ãããã«äººäœã«å±éºãæ¥æ¬äººãç¥ãã¹ãã§ããã
ãããã人éã¯çåæ¹æ³ã®å£çµãã§ããªãããããªçãç©ã§ããã
æ¥æ¬ããããªã£ãŠæ¬²ãã
æ°åã³ããã®mRNAã¯ã¯ãã³æäžããè¡çºãç¯çœªåãã¢ã€ããå·ã§æ°æ³æ¡ãè°äŒã«æåºãããŸããã
SNSã®æ å ±ãä¿¡ãããããã¡ã€ã¶ãŒç€Ÿãã¢ãã«ã瀟ãã¹ãã³ãµãŒã®æ¥æ¬ã®ãã¹ã³ãã®æ å ±ãä¿¡ãããã¯å人ã®èªç±ã§ãã
ã¯ã¯ãã³æ¥çš®ããŠé節ãªå¯åå¿ã§æ»äº¡ããã®ãèªå·±è²¬ä»»ã§ãã
SNSã®æ å ±ãä¿¡ãããããã¡ã€ã¶ãŒç€Ÿãã¢ãã«ã瀟ãã¹ãã³ãµãŒã®æ¥æ¬ã®ãã¹ã³ãã®æ å ±ãä¿¡ãããã¯å人ã®èªç±ã§ãã
ã¯ã¯ãã³æ¥çš®ããŠé節ãªå¯åå¿ã§æ»äº¡ããã®ãèªå·±è²¬ä»»ã§ãã
ãç¯çœªåãã¢ã€ããå·ã§æ°æ³æ¡
âŠâŠ
âŠâŠ
âŠæ¥æ¬ð¯ðµã§ã æ¯éâïž
mRNAæäž ç¯çœª
ãããããããã¥ãŒã¹ã§ããïŒïŒã¢ã¡ãªã«ã®äžéšã®å·ã§ãããã¯ã¯ãã³ãæäžããè
ã眰ããæ³æ¡ãåºãããŸããïŒïŒã€ãã«ãã€ãã«ã§ãðâ¥ã
ã³ããã¯ã¯ãã³ã¯äžåºŠãæã£ãŠãŸãã å±éºã ãšç¥ã£ãŠãããã
ã¢ã€ããå·ã«ã¯ãããªã¢ããªæ³æ¡ãè°äŒã«æåºããè°å¡ãããã£ãŠèšäºãªã®ã«ãåã¯ã¯ããã鬌ã®éŠããšã£ãããã«èšäºã玹ä»ããŠãããªwww
çŽ æŽããã è±æã§ãã
ïœRNAæè¡ã¯æªã çºå±æ®µéã人ãžã®æ¥çš®ã¯ãªã¹ã¯ãé«éããŸãã
æ¯æããŸãïŒ
ïœRNAæè¡ã¯æªã çºå±æ®µéã人ãžã®æ¥çš®ã¯ãªã¹ã¯ãé«éããŸãã
æ¯æããŸãïŒ
ã¢ã€ããð
æ°åã³ããã®mRNAã¯ã¯ãã³
æäžãç¯çœªåãã¢ã€ããå·ã§æ°æ³æ¡ âŒïž
ãã®ãã¿âŠ
å£ãæãããã®ããã«
çµç¹ç³»åã¯ã¯ã¢ã«ãŠã³ãã
äžæã«ãã€ãŒãããŠããªâŠð
æ¥æ¬äººã«ã¯ããéçšããªããã
æäžãç¯çœªåãã¢ã€ããå·ã§æ°æ³æ¡ âŒïž
ãã®ãã¿âŠ
å£ãæãããã®ããã«
çµç¹ç³»åã¯ã¯ã¢ã«ãŠã³ãã
äžæã«ãã€ãŒãããŠããªâŠð
æ¥æ¬äººã«ã¯ããéçšããªããã
ãããã話ãããããããµããäžã§ã颚éªçšåºŠã«ãªã£ãç
æ°ã«å¯ŸããŠmRNAã¯ããæãŠããªãã
æ¥æ¬ã¯å¹³åã ãããã
æ¥æ¬ã¯å¹³åã ãããã
ããã«ãããŠç¬ããªã
ãšãŠãåŠå®çãªèšãåãã ããã©ã€ã¿ãŒã®ã®ãªã®ãªã®çºä¿¡ã§ããæ°ãããã
ããïŒæ¥æ¬ã§ã¯å
¬ç¶ãšæšé²ãããŠãŸããïŒããããé«éœ¢è
ã¯åãã§æ¥çš®ããŠãŸãã
Yahooãã¥ãŒã¹ã§ãåãäžããã®ã¯æå€ã ãã
ã¢ã€ããå·
æ°åã³ãããŠã€ã«ã¹ææçïŒCOVID-19ïŒã®
mRNAïŒã¡ãã»ã³ãžã£ãŒRNAïŒã¯ã¯ãã³ã
æäžããè¡çºã
軜ç¯çœªãšã¿ãªãæ³æ¡ãè°äŒã«æåºãã
ã¡ãã»ã³ãžã£ãŒãªãæ žé žæè¡
ãè¡æ ãå¿èã®åé¡ãæžå¿µããæ å ±
æ°åã³ãããŠã€ã«ã¹ææçïŒCOVID-19ïŒã®
mRNAïŒã¡ãã»ã³ãžã£ãŒRNAïŒã¯ã¯ãã³ã
æäžããè¡çºã
軜ç¯çœªãšã¿ãªãæ³æ¡ãè°äŒã«æåºãã
ã¡ãã»ã³ãžã£ãŒãªãæ žé žæè¡
ãè¡æ ãå¿èã®åé¡ãæžå¿µããæ å ±
æž
ã
ãããª
ã¢ã¡ãªã«ã®ã¢ã€ããå·ã§ã¯ãã³ããã¯ã¯ãã³ã泚å°ããå»åž«ãé®æããæ³åŸãäœãããŸãããæ¥æ¬ã倧è¬å®³ãšãªã£ãŠæéã®åé¡ã§ããïŒïŒ
æ¥ããïœã
ã«è
å
é£ã岞ç°å
é£ã®åé£åããã殺人眪ã殺人æªé眪çã§æ±äº¬å°æ€ã«åäºåçºãã件ãé²ããŠãã ãããæ±äº¬å°æ¹æ€å¯åºãã
ãããäžäžããªã¹ãæåç䞻矩
å®æåœå®¶ã¢ã¡ãªã«
å®æåœå®¶ã¢ã¡ãªã«
ãããªããšã¢ã€ããã¯æ°ã¥ããŠãŸãããæ¥æ¬ã¯ãŸã æã€ããã§ãã
Twitterã®ååã®æ«å°Ÿã«ãæ°ä»ãã人ããšãå
¥ããŠãããªãã€ãŒããããã€ã±ããããããïŒ
ã 軜ç¯çœªãªããŠããããããŒã(
ãããã¢ã¡ãªã« ç¬ã
ã»mRNAã¯ã¯ãã³ãæäžããè¡çºã軜ç¯çœªãšã¿ãªãæ³æ¡ãè°äŒã«æåºããã
ã»å ±åå ã®ã¿ããŒã»ãã³ã«ãºå·äžé¢è°å¡ãšãžã¥ãã£ã»ãã€ã«å·äžé¢è°å¡ãå ±åææ¡ãã
ã»ãªãªãããããžãªã©ã®åç©ãžã®æäžã察象
â
ã»å ±åå ã®ã¿ããŒã»ãã³ã«ãºå·äžé¢è°å¡ãšãžã¥ãã£ã»ãã€ã«å·äžé¢è°å¡ãå ±åææ¡ãã
ã»ãªãªãããããžãªã©ã®åç©ãžã®æäžã察象
â
æ¶æãããããªå ±éå
容ã§ãã¹ãªãŒãã£ã³ã°
æ³æ¡æåºè ïŒã¢ã¿ãªã«ãšèªå°ããŠã
æªæã®ããèšèŒ
æ³æ¡æåºè ïŒã¢ã¿ãªã«ãšèªå°ããŠã
æªæã®ããèšèŒ
ãã£ãšãåœããåã®æ³æ¡ãåºã ããã
ãããªç§åŠçã«ç Žç¶»ããã¯ã¯ãã³ãªããŠåŒã¹ããããããªãçç©è£œå€ã人ã«æã€ãªããŠã©ãèããŠãããããªãã
ãããªç§åŠçã«ç Žç¶»ããã¯ã¯ãã³ãªããŠåŒã¹ããããããªãçç©è£œå€ã人ã«æã€ãªããŠã©ãèããŠãããããªãã
é®æððšð®ãããå»åž«äŒã
ã³ããã¯ã¯ãã³ãæ¥çš®ããæ¹ã
ãããžã§ãæå·æ§ã ãªã
éæ¥çš®ã貫ããŠæ¬åœã«è¯ãã£ãããŒã
éæ¥çš®ã貫ããŠæ¬åœã«è¯ãã£ãããŒã
èªå·±è²¬ä»»ãèªèº«ãç²åŸããç¥èã§ãªã¹ã¯ãšã¡ãªããã®äœåŠã«ç·åŒããã°ãããå€æãããããããšããã®æ ¹åºã«ã¯å¥åº·ãšåœãããäžã§ãä»äººã«ã©ãã®ããã®ãšããã®ã¯äºã®æ¬¡ãâ¶
ãã®ãã¥ãŒã¹ã§éšãã®ã¯ãŸã æ©ã
æ¥æ¬ãæ©ãâŒïž
奎çã®è¡çºã決ããŠèš±ããŠã¯ãããªãâŒïž
奎çã®è¡çºã決ããŠèš±ããŠã¯ãããªãâŒïž
ãããããå»è
ã¯ã¢ã€ãããžè¡ã
ç±³ã¢ã€ããå·ã§ã¯ãæ°åã³ããã®mRNAã¯ã¯ãã³ã®æäžãç¯çœªåããæ°æ³æ¡ãè°äŒã«æåºãããããã§ããå
ã
ãå»åž«ã¬ãã«ã§ã¯ãªããäžçã¬ãã«ã§ã®äººé¡ã«å¯Ÿããèä¿¡è¡çºãªã®ã§ã軜ç¯çœªã§ã¯æžãŸãªãã®ã§ããã©ããããããã倧èã«å¯Ÿçãè¬ããŠããããããªãææã«ãªããŸããã
ðºðžã¢ã€ããå·
ãã³ããã¯ã¯ãã³ãæã£ããç¯çœªãæ³æ¡ïŒïŒïŒ
ãã³ããã¯ã¯ãã³ãæã£ããç¯çœªãæ³æ¡ïŒïŒïŒ
ã ããã¯ã¯ãã³æã£ã¡ããã¡ã£ãŠèšã£ãã§ããã
åã¯ã¯ã£ãŠé ã®ãããã奎æ±ãããããã©ç§ã®æ¹ãæ£ããã£ã
åã¯ã¯ã£ãŠé ã®ãããã奎æ±ãããããã©ç§ã®æ¹ãæ£ããã£ã
ã³ããã¯ã¯ãã³çµ¶å¯Ÿæã®å€ãªå®¢ãžã®ãã¿ããŸãã²ãšã€å¢ãããã
ç¯çœªã§ãã£ãŠïŒ
åœç¶ã£ã¡ãåœç¶ãã
ãæ¬ãèªãã
ããã ã
ããã ã
å»åŠå士ããã®ã³ã¡ã³ã
ããã£ãšæ¬ãèªã¿ãªããã
ããã£ãšæ¬ãèªã¿ãªããã
ãã³ãã³ãæãæŽãBakaãå¿œé£ãã¢ã³ãã³å€ªéã¯ããã®èšäºãã©ãèå¯ãããã ããã
ãã¯ãå šå¡ãäœããªãã£ããã®ãããªãç¥ãã¬é¡ã貫ãããšããŠãŸãããç·æ¬ã»æ¯è¿ããçµãããŸã§ã絶察ã«èš±ããªããããªã
èã床ïŒâ â â â â âŠ
ãã¯ãå šå¡ãäœããªãã£ããã®ãããªãç¥ãã¬é¡ã貫ãããšããŠãŸãããç·æ¬ã»æ¯è¿ããçµãããŸã§ã絶察ã«èš±ããªããããªã
èã床ïŒâ â â â â âŠ
ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãä»ã®ã¯ã¯ãã³ã¯ãããªããšã«ãªããªãã®ã§ããã£ã±ãmRNAã¯ã¯ãã³ã¯è¬å®³ã¯ã¯ãã³ãªãã ãã
mRNAã¯ã¯ãã³æäžã¯ç¯çœªãæ³æ¡æåº
åæã®å»çåŸäºè
ããç±³é£åå»è¬åå±ïŒFDAïŒã®èªå¯ããã¯ã¯ãã³ãæäžããã ãã§åäºçœ°ãåããæããããã
ã¯ã£ïŒåæã®å»çåŸäºè ïŒ
å¯èšã¯å¯ãŠèšãïŒïŒïŒ
éã«é£ãããã ãã ãããð¢
ã¯ã£ïŒåæã®å»çåŸäºè ïŒ
å¯èšã¯å¯ãŠèšãïŒïŒïŒ
éã«é£ãããã ãã ãããð¢
ãããã¢ã€ããå·è¡ã£ãŠæ¥ãïŒ
æ°åã³ããmRNAã¯ã¯ãã³æäžãç¯çœªåãã¢ã€ããå·ã§æ°æ³æ¡
åãå§ããŠãããã
æªãäºãèãã人ã¯ææãããã¹ãã§ãã